We analyze phototherapy rates after implementation of a Hyperbilirubinemia Clinical Pathway (HCP), which placed full-term ABOi DAT negative newborns on the low risk phototherapy nomogram, rather than ...
Determine whether management of neonatal hyperbilirubinemia differs if one used end-tidal carbon monoxide (CO) corrected for ambient CO (ETCO c) measurements instead of direct antiglobulin test (DAT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results